Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released May 12, 2026, before the open
10-Q filed May 12, 2026, 42 days after period end · 0001171843-26-003311
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $20.76M | $21.77M | $24.51M | $29.98M |
| Net Income | -$3.42M | -$50.34M | -$4.69M | $622.00K |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.77 |
| -$11.42 |
| -$0.11 |
| $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
